Invention Grant
- Patent Title: Interleukin-10 fusion proteins
- Patent Title (中): 白细胞介素-10融合蛋白
-
Application No.: US13959051Application Date: 2013-08-05
-
Publication No.: US09346872B2Publication Date: 2016-05-24
- Inventor: Lydia Jasmin Duerner , Thomas Emrich , Jens Fischer , Ralf Hosse , Ekkehard Moessner , Pablo Umana , Daigen Xu
- Applicant: Roche Glycart AG
- Applicant Address: CH Schlieren
- Assignee: ROCHE GLYCART AG
- Current Assignee: ROCHE GLYCART AG
- Current Assignee Address: CH Schlieren
- Agency: Jones Day
- Priority: EP12179709 20120808
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C07K14/54 ; A61K38/20 ; C07K16/40
Abstract:
The present invention generally relates to fusion proteins of antibodies and interleukin-10 (IL-10). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease.
Public/Granted literature
- US20140044674A1 INTERLEUKIN-10 FUSION PROTEINS AND USES THEREOF Public/Granted day:2014-02-13
Information query
